Method of treating lesions in a nervous system

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 2, 530399, 435 694, 536 2351, 536 235, 930120, A61K 3818

Patent

active

056565968

ABSTRACT:
The invention relates to a neurite-promoting factor released by glial cells, to related proteins and fragments thereof retaining their neurite-promoting activity, to DNAs coding for the amino acid sequence of the neurite-promoting factor and fragments thereof, to hybrid vectors containing such DNAs, to hosts transformed with such a hybrid vector, to processes for the preparation of the DNAs, vectors and transformed hosts, to processes for the manufacture of the neurite-promoting factor, related proteins and its fragments, and to their use in the treatment of lesions in the nervous system.

REFERENCES:
patent: 3985722 (1976-10-01), Yoshida et al.
patent: 4394443 (1983-07-01), Weissman et al.
patent: 4468464 (1984-08-01), Cohen et al.
patent: 4556643 (1985-12-01), Paau et al.
patent: 4703107 (1987-10-01), Monsigny et al.
patent: 5112608 (1992-05-01), Scott et al.
patent: 5278049 (1994-01-01), Baher et al.
D. Mondard et al., Proc. Nat. Acad. Sci. 70, pp. 1894-1897 (1973).
Y. Schurch-Rathgeb et al., Nature 273, pp. 308-309 (1978).
J. Guenther et al., The EMBO Journal 4, pp. 1963-1985 (1985).
R. W. Scott et al., J. Biol. Chem. 260, pp. 7029-7033 (1985).
G. E. Davis et al., TINS 1985, pp. 528-532 (1985).
S. Gloor, J. Guenther, D. Monard and H. Nick, J. Guenther and D. Monard, both in Experientia, 42, 631 (1987).
Gloor, S., et al., Cell, vol. 47, 687-693, (1986).
Sommer, Juerg, et al., Biochemistry, 26, 6407 (1987).
Shea, T.B., (1991) "Transient neuritogensis in NB2a/d1 neuroblastoma cells induced by glial-derived protease inhibitors," Cell. Biol. Intl. Rpts., 15:437-443.
Spendlove, R.S., 1995 in: Art to Science. In Tissue and Cell Culture. vol. 14(1), 1995, HyClone Laboratories Newsletter, pp. 1, 2, 5-7.
Gurwitz et al., (1988) "Thrombin modulates and reverses neuroblastoma neurite outgrowth," Proc. Natl. Acad. Sci. USA, 85:3440-3444.
Hu et al., (1988) "Expression of the cDNA for mouse beta-nerve growth factor protein in Escherichia coli," Gene, 70:57-65.
Burton et al., (1992) "Activity and biospecificity of proteolyzed forms and dimeric combinations of recombinant human and murine nerve growth factor," J. Nuerochem., 59:1937-1945.
Hamel et al., (1993) "Neurotrophin gene expression by cell lines derived from human gliomas," J. Neurosci. Res., 34:147-157.
Shea et al., (1992) "Sequential effects of astroglial-derived factors on neurite outgrowth: initiation by protease inhibitors and potentiation by extracellular matrix components." J. Neurosci. Res., 31:309-317.
Gurwitz et al., (1990) "Neurite outgrowth activity of protease nexin-1 on neuroblastoma cells requires thrombin inhibition," J. Cell. Physiol., 142:155-162.
Cunningham et al., (1989) "Proteolytic regulation of neurite outgrowth from neuroblastoma cells by thrombin and protease nexin-1," J. Cell. Biochem., 39:55-64.
Kligman et al., (1987) "Neurite extension factor induces rapid morphological differentiation of mouse meuroblastoma cells in defined medium," Brain Res., 430:296-300.
Mahonen et al., (1985) "Adhesive membrane protein of rat brain enhances neurite outgrowth of neuroblastoma cells," Eur. J. Cell. Biol., 36:91-97.
Meier et al., (1989) "Induction of a glia-derived nexin after lesion of a peripheral nerve," Nature, 342:548-550.
Shea, T. B. 1991 Cell Biol. Intl. Rpts. 15(5):437-443.
Spendlove, R. S. 1995 in:Art to Science. In Tissue and Cell Culture. vol. 14(1), 1995, HyClone Laboratories Newsletter, pp. 1, 2, 5, -7.
Stedtman's Medical Dictionary, 25th edition, (Hensyl et al., eds.), Williams and Wilkins, Baltimore, MD, pp. 1139, 1140, and 1610.
Pharmaceutical Sciences , 1990 Mack Publ. Co., Easton, PA, p. 387.
ATCC Catalog of Cell Lines & Hybridomas, 1988, American Type Culture Collection. Hay et al. (eds.) 1988, Rockville, MD, p. 78.
Stryer, L. 1975. in: Biochemistry. W. H. Freman and Co. San Francisco. pp. 336-337.
Scott, et al. 1985. J. Biol. Chem. 260, 7029-7034.
McGrogan et al. 1988 Bio/Technol. 6, 172-177.
Wallace et al. 1980. Nuc. Acids Res. 9, 879-894.
Beaucage et al. 1981 Deoxynucleoside phosphoramidites--a new class of key intermediates for deoxypolynucleotide synthesis. Tet. Ltrs. 22, 1859-1862.
Guenther et al. 1985 A glia-derived neurite-promoting factor with protease inhibitory activity. EMBO J. 4, 1963-1966.
Robson et al. (eds.) 1986 Introduction to Proteins and Protein Engineering, Elsevier, New York. pp. 34-39.
Hay et al. (eds.) 1988 American Type Culture Collection Catalogue of Cell Lines and Hybridomas Sixth Edition. Rockville, MD p. 239.
Vieira et al. 1982 The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers Gene 19, 259-268.
Gerhardt et al. 1981 Manual of Methods for General Bacteriology Am. Soc. for Microbiol. Washington, D. C. pp. 329-332.
Beck et al. 1995 Nature 373: 339-341.
Henderson, Z. 1996 Progress in Neurobiology 48: 219-254.
Sjostrom et al. 1987 Signal peptide amino acid sequences in Escherichia coli contain information related to final protein localization. A multivariate data analysis. EMBO J. 6, 823-831.
Clark-Lewis et al. 1986 Automated chemical synthesis of a protein growth factor for hematopoietic cells, interleukin-3. Science 231, 134-139.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method of treating lesions in a nervous system does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating lesions in a nervous system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating lesions in a nervous system will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-160496

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.